Abiraterone Acetate Tablets 500 Mg – Advanced Treatment for Prostate Cancer

Overview

Abiraterone Acetate 500 mg is a life-extending treatment for men with advanced prostate cancer, specifically metastatic castration-resistant prostate cancer (mCRPC). This form of prostate cancer continues to progress even when testosterone levels are reduced to extremely low levels (medically castrated).

Abiraterone 500 mg works by inhibiting the activity of CYP17, an enzyme necessary for the production of androgens (male hormones like testosterone) in the body. Since androgens can fuel the growth of prostate cancer cells, suppressing their production can slow or halt progression of the disease.

Key Features and Benefits

• High-Strength Dose: Fewer tablets required daily compared to traditional 250 mg versions.
• Generic Version of Zytiga: Offers the same active ingredient and therapeutic effects at a lower cost.
• Taken with Prednisone: Reduces risk of corticosteroid-related side effects and enhances efficacy.
• Oral Administration: Easy-to-take tablet, swallowed whole with water.
• GMP Certified Manufacturing: Produced in certified, high-quality pharmaceutical facilities.

Mechanism of Action

Abiraterone Acetate interferes with androgen biosynthesis by blocking CYP17A1 enzyme activity. This dual-function enzyme plays roles in both adrenal and testicular androgen production. Inhibiting CYP17 reduces blood levels of testosterone, which can deprive prostate cancer cells of necessary fuel, stopping or slowing tumor growth.

When combined with prednisone, it also helps manage the body’s reaction to androgen suppression, helping maintain a reliable treatment pathway while managing fluid balance, inflammation, and other hormone-mediated effects.

Recommended Usage

• Dosage: One 500 mg tablet taken once daily, on an empty stomach (no food 2 hours before or 1 hour after taking).
• Co-Therapy: Typically prescribed with prednisone 5 mg, twice daily.
• Duration: As determined by oncologist based on treatment response and disease progression.
• Do Not Crush or Split: Tablets must be swallowed whole with water.

Dose-optimized targeted therapy programs may incorporate Axitinib Tablets 5 Mg – Generic Inlyta within physician-directed kidney cancer management strategies.

Safety Information

Patients must undergo evaluations before and during treatment to monitor liver function, blood pressure, and potassium levels. Routine PSA (prostate-specific antigen) tests are also key to tracking treatment progress.

Common Side Effects:

• High blood pressure (hypertension)
• Low potassium
• Liver enzyme abnormalities
• Joint pain or swelling
• Fatigue
• Fluid retention

Serious Side Effects (rare but require immediate attention):

• Liver toxicity
• Adrenal insufficiency
• Cardiac arrhythmia

Targeted oncology treatment programs may include Afatinib Tablets 30 Mg – Generic Gilotrif as part of physician-supervised lung cancer therapy plans.

Storage Instructions

• Keep at room temperature (20–25°C or 68–77°F).
• Protect from moisture, heat, and direct sunlight.
• Store in original packaging.
• Keep out of reach of children and pets.

Proper medication storage conditions and pharmaceutical stability guidance can also be referenced through patient drug information provided by MedlinePlus.

Who Should Not Take Abiraterone Acetate

• Women (especially those who are pregnant or may become pregnant)
• Children and adolescents
• Patients with severe liver disorder
• Patients allergic to Abiraterone or any of the excipients
• People not prescribed this medication—never take without medical supervision

Regulatory Status

• Prescription-only medication
• Approved by the FDA and EMA as a generic alternative to Zytiga
• Manufactured according to cGMP and international pharmaceutical standards

FAQ’s